FeelGood vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Visit Oak Longevity - our pick of these two →or find your match

Oak Longevity beats FeelGood overall, scoring 7.5/10 vs 7/10. Published pricing is not a like-for-like monthly comparison: FeelGood is from $149/mo; Oak Longevity is from $119/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side look at FeelGood and Oak Longevity to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

FeelGood

#41 of 54

7/10

Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.

Visit FeelGood

Higher Rated

Oak Longevity

#21 of 54

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	FeelGood	Oak Longevity
Why each one	One of the cheapest compounded-semaglutide entry points ($149/mo) that ALSO offers an oral tablet route and a money-back weight-loss guarantee, backed by LegitScript approval, a combination uncommon at the budget end of the market.	The no-subscription billing model, patients are not auto-charged each month and renew manually. Combined with the broadest medication mix (compounded GLP-1s + oral Wegovy + brand-name + longevity peptides), Oak occupies a unique position as a 'menu' platform vs. the typical single-product flow.
Our Score	7/10	7.5/10
Headline Price	from $149/mo	from $119/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out for	Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake	Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
Ranking	#41	#21
Get started	Visit FeelGood	Visit Oak Longevity

Pros & Cons Compared

FeelGood

Pros

+Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
+Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients, a non-injectable route only a handful of platforms provide
+LegitScript-approved, independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
+Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included

Cons

−Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake
−$149 is a 'starting' price (dose-escalating), not flat across all doses, your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
−Brand-name 'original' semaglutide injection at $1,999/mo is far above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent, and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Never buy brand-name through FeelGood
−No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site, thin corporate and clinical transparency
−Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15-20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
−Compounded GLP-1s are not FDA-approved (none are), and FeelGood offers compounded semaglutide only, no tirzepatide

Oak Longevity

Pros

+$119/mo for compounded semaglutide is among the lowest published entries in our provider table
+No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Compounded tirzepatide at $185/mo is competitively priced for a GLP-1+GIP dual agonist
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
−No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
−The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
−The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Oak Longevity edges out FeelGood with a score of 7.5/10 vs 7/10. Published pricing is not a like-for-like monthly comparison: FeelGood is from $149/mo; Oak Longevity is from $119/mo. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).